Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Cancer Chemother Pharmacol. 2012 Feb 15;69(6):1657–1667. doi: 10.1007/s00280-012-1839-5

Figure 2.

Figure 2

Concentration values of imatinib (A), P=0.44, and its metabolite CGP74588 (B), P=0.007, in the absence of flavopiridol, immediately prior to infusion (at 24 h) and in the presence of flavopiridol, immediately after the 1-hr infusion (at 25 h) (N=15).